SPL starpharma holdings limited

ASCO Presentations 2024

  1. 13,197 Posts.
    lightbulb Created with Sketch. 1622







    2024 ASCO Annual Meeting


    2024 ASCO Annual Meeting
    Oral Abstract Session

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
    June 1 – 3:00 PM CDT
    location_onHall D1




    2024 ASCO Annual Meeting
    Rapid Oral Abstract Session

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
    June 3 – 8:00 AM CDT
    location_onS406
    Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.

    8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.0¢
Change
-0.005(4.00%)
Mkt cap ! $50.18M
Open High Low Value Volume
12.0¢ 12.5¢ 11.5¢ $3.755K 31.66K

Buyers (Bids)

No. Vol. Price($)
2 63402 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 106947 2
View Market Depth
Last trade - 15.41pm 12/09/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.